Nucleo
Nucleo builds AI agents that help oncologists and radiologists pull measurements and insights out of CT scans to characterise tumours and guide treatment.
Overview
Nucleo describes itself as the first agentic platform for oncology: software agents that analyse CT scans to support tumour characterisation, measurement and treatment decisions for oncologists and radiologists. The company states that it works with Stanford Hospital, Cedars-Sinai, UCI Health and Weill Cornell. It is a Fall 2025 YC company with a two-person team; its YC profile gives no headquarters city, so only the country is recorded. Regulatory status and validation data have not been published.
Funding
All startupsPages like this
not linked directly; found by shared links- CompanyAluna
Shares Y Combinator and the tag yc.
- CompanyLiyfe
Shares Y Combinator and the tag yc.
- CompanyMednet (theMednet)
Shares Y Combinator and the tag yc.
- CompanyREPROSENT
Shares Y Combinator and the tag yc.
- CompanyiSono Health
Shares Y Combinator, AI in radiology and the tag yc.
- CompanyAlixia
Shares Y Combinator and the tag yc.
- CompanyVelorum Therapeutics
Shares Y Combinator and the tag yc.
- CompanyDelee
Shares Y Combinator and the tag yc.